Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04270747
What this trial is testing

Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Amgen 576
Large-scale testing (Phase 3)Looking for participantsNCT07695207
What this trial is testing

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
SANGMYUNG innovation 266
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)Study completedNCT00964795
What this trial is testing

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Regeneron Pharmaceuticals 323
Testing effectiveness (Phase 2)Ended earlyNCT03869684
What this trial is testing

Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Senju Pharmaceutical Co., Ltd. 13
Not applicableUnknownNCT01676506
What this trial is testing

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Russian Academy of Medical Sciences 300
Post-approval studies (Phase 4)Study completedNCT02060604
What this trial is testing

Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Università degli Studi di Brescia 60
Post-approval studies (Phase 4)Study completedNCT03022292
What this trial is testing

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Who this might be right for
Wet Macular Degeneration
University of California, Los Angeles 26
Testing effectiveness (Phase 2)Study completedNCT00138632
What this trial is testing

Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis 50
Post-approval studies (Phase 4)Study completedNCT02130024
What this trial is testing

A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 281
Large-scale testing (Phase 3)Study completedNCT00321997
What this trial is testing

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 540
Not applicableUnknownNCT05675540
What this trial is testing

Artificial Intelligence Diagnostic Aid

Who this might be right for
Wet Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Guy's and St Thomas' NHS Foundation Trust 422
Early research (Phase 1)Study completedNCT03814291
What this trial is testing

A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 31
Large-scale testing (Phase 3)Study completedNCT07389577
What this trial is testing

Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Jecho Biopharmaceuticals Co., Ltd. 443
Post-approval studies (Phase 4)Study completedNCT01810042
What this trial is testing

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Pusan National University Hospital 49
Not applicableUnknownNCT00893724
What this trial is testing

Supplemental Adjuvants for Intracellular Nutrition and Treatment

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Mid-Atlantic Retina Consultations, Inc. 60
Post-approval studies (Phase 4)Study completedNCT02142296
What this trial is testing

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

Who this might be right for
Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Early research (Phase 1)Ended earlyNCT01086761
What this trial is testing

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Allergan 32
Testing effectiveness (Phase 2)Study completedNCT02140151
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Southern California Desert Retina Consultants, MC 108
Large-scale testing (Phase 3)Study completedNCT05989126
What this trial is testing

Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-Related Macular Degeneration (nAMD)
Regeneron Pharmaceuticals 35
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation